Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Lithium was associated with a higher risk of thyroid and kidney ...

This is the fifth post in a series on non-pharmacologic treatments of bipolar disorder. Previous posts briefly reviewed the evidence for amino acids, the B vitamin choline, and a proprietary nutrient ...

For many people who have bipolar I, lithium is that most elusive of pharmacological treatments, the “magic bullet”—a single intervention that completely eliminates the symptoms of a disease. Since the ...

Lithium is safe and tolerable as maintenance therapy for up to 28 weeks for children and teens with bipolar disorder (BD), new research suggests. A randomized, double-blind study showed that ...

Neurologists have provided new insights into how lithium, a mood-stabilising drug, dampens hyperactive neurons in patients with bipolar disorder 1. Lithium treatment is known to soothe an agitated ...

Changes Clinical Practice: Based on this large trial, lithium alone or a lithium-valproate combination should be used as first-line maintenance treatment for bipolar affective disorder type I instead ...

The lead researcher from HKUMed, Dr Chang Wing-chung (centre), highlights that the study reinforces the therapeutic value of lithium, showing its safe use in managing bipolar disorder with proper ...

Compared with lithium, valproate, olanzapine, quetiapine, and risperidone generally exhibited a lower likelihood of thyroid dysfunction. HealthDay News — Lithium is associated with an increased risk ...

Higher lithium serum levels linked to elevated rates of hypothyroidism, hyperthyroidism, and CKD3+. (HealthDay News) — Lithium is associated with an increased risk for thyroid dysfunction and chronic ...

ATLANTA--(BUSINESS WIRE)--Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for ...